Multimodal Brain Imaging Phenotypes and Genetic Associations in Duchenne Muscular Dystrophy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500096836

Enrollment

Unknown

Registered

2025-02-07

Start date

2025-03-10

Completion date

Unknown

Last updated

2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duchenne muscular dystrophy

Interventions

1:N/A

Eligibility

Sex/Gender

Male

Age

5 Years to 30 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed with muscular dystrophy through genetic testing and muscle biopsy; (2) No metallic implants in the body, suitable for MRI scanning; (3) No history of organic brain disease; (4) No history of neurological or psychiatric disorders; (5) Understand the potential risks and benefits, agree to participate in the study, comprehend the research procedures, and consent to complete follow-up visits and comply with the study protocol requirements.

Exclusion criteria

Exclusion criteria: (1) Presence of contraindications for MRI scanning; (2) History of taking antipsychotic medications or having taken sedative medications within the past 2 weeks.

Design outcomes

Primary

Measure	Time frame
brain structure;brain function;	—

Secondary

Measure	Time frame
genomics;	—

Countries

China

Contacts

Public ContactHuayan Xu

West China Second Hospital, Sichuan University

xuhuayan89@sina.com+86 158 8240 8848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026